Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
Awards highlight Avantor's commitment to the Biopharma industry
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
PRX-PLUS has a unique product feature with its deep-impacting formula
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Subscribe To Our Newsletter & Stay Updated
